Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05047965

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

Evaluation of MRI With Dixon Based Sequences in the Detection of Prostate Cancer

Status
Active Not Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
65 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate prospectively the accuracy of Dixon based sequences in detection of intraprostatic tumor nodules. II. Determine the sensitivity, specificity, positive and negative predictive value of Dixon based sequences in assessment of extraprostatic tumor extension and lymph node involvement. SECONDARY OBJECTIVES: I. Compare the accuracy of Dixon based sequences versus multiparametric diffusion weighted imaging including diffusion tensor imaging in tumor detection and extraprostatic extension. II. Compare the accuracy of Dixon based sequences in detection of transition zone tumors. III. Determine the optimal scanning parameters for Dixon based sequences in the imaging of prostate adenocarcinoma. OUTLINE: Patients undergo MRI with additional Dixon based sequences with fat and water over a total of 49 minutes.

Conditions

Interventions

TypeNameDescription
PROCEDUREDixon MRIUndergo Dixon MRI
PROCEDUREMagnetic Resonance ImagingUndergo standard MRI

Timeline

Start date
2013-04-25
Primary completion
2027-02-02
Completion
2027-02-02
First posted
2021-09-17
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05047965. Inclusion in this directory is not an endorsement.